NASDAQ: LPTXLeap Therapeutics Inc Stock Ownership - Who owns Leap Therapeutics?
Insider buying vs selling
Have Leap Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when LPTX insiders and whales buy or sell their stock.
LPTX Shareholders
What type of owners hold Leap Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Perceptive Advisors LLC | 33.16% | 8,476,496 | $11.87M | Insider |
| Douglas E. Onsi | 31.33% | 8,009,655 | $11.21M | Insider |
| Beigene Ltd | 28.74% | 7,348,437 | $10.29M | Insider |
| Augustine Lawlor | 22.77% | 5,821,791 | $8.15M | Insider |
| Christopher Mirabelli | 22.77% | 5,821,791 | $8.15M | Insider |
| Healthcare Ventures Ix LP | 16.21% | 4,144,804 | $5.80M | Insider |
| James H. Cavanaugh | 10.24% | 2,618,406 | $3.67M | Insider |
| John W. Littlechild | 10.24% | 2,618,406 | $3.67M | Insider |
| Lilly Co Eli | 5.79% | 1,479,307 | $2.07M | Insider |
| Baker Bros Advisors LP | 4.59% | 1,172,175 | $1.64M | Institution |
LPTX vs Biotech Stocks
Leap Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.